This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92662457
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article scientifique publié en 2019 artículu científicu espublizáu en xunu de 2019 2019 թվականի հունիսի 12-ին հրատարակված գիտական հոդված scientific article published on 12 June 2019 наукова стаття, опублікована 12 червня 2019 im Juni 2019 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q92662457-7218B8F6-FAA2-48A7-BD40-CABA3974C01C
wdt:P577
2019-06-12T00:00:00Z
p:P2093
wds:Q92662457-253CE3D3-88D1-49D4-B98B-7EDAA619C8E8 wds:Q92662457-B1DA21F0-22A3-4143-8138-728907D49DD0 wds:Q92662457-9D4C6902-6ACD-403A-A3B4-5AA609B01585
wdt:P2093
David J Cohen William Lombardi William J Nicholson
rdfs:label
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention
skos:prefLabel
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention
schema:name
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention
p:P50
wds:Q92662457-B5DE657A-3870-4FBF-9103-CCF458122CBC wds:Q92662457-845833DB-D7E4-4A86-95FD-9052CC9A99B5 wds:Q92662457-9D991D03-A03D-49CC-9E9A-1EEF5221D8E9 wds:Q92662457-7A043A5B-CB62-4FBB-A946-AB2FE44A476E wds:Q92662457-81BCEF82-710E-4FC6-9835-1AF4F109094A wds:Q92662457-8318E8F8-124D-46FA-ACDC-DE088D23C05C wds:Q92662457-459CA4A3-0984-4E7C-9797-0B7525DF6BA3 wds:Q92662457-4621ED30-A967-4250-B9C2-A0D788D541B6 wds:Q92662457-3A742F9F-484D-46C5-952B-6753475BEE77 wds:Q92662457-00274C99-F8F2-48ED-8FF0-CCD5ECF09E40
wdt:P50
wd:Q88413664 wd:Q89957514 wd:Q114335733 wd:Q64779134 wd:Q89729574 wd:Q89656452 wd:Q87858080 wd:Q96952468 wd:Q59976170 wd:Q106777665
p:P1476
wds:Q92662457-3E358888-56F0-425A-9300-1064F47B585F
wdt:P1476
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention
p:P304
wds:Q92662457-3B4CF965-7E9F-4B99-B672-731025E3115B
wdt:P304
e005287
p:P31
wds:Q92662457-2EA68480-5B20-482E-8F9A-FC226FE2FF2B
wdt:P31
wd:Q13442814
p:P698
wds:Q92662457-CA877A22-BA39-40CF-8DC7-44C6A73742DF
wdtn:P698
n10:31185735
wdt:P698
31185735
p:P1433
wds:Q92662457-A572271A-B6AA-4567-9137-72F6F25CD9C4
wdt:P1433
wd:Q15816436
p:P433
wds:Q92662457-17A868AD-E0AB-4A96-B5A9-142CD67EA667
p:P478
wds:Q92662457-2EB6A014-AC9B-4066-94A7-3026EABEC440
wdt:P433
6
wdt:P478
12
p:P356
wds:Q92662457-27F67F26-AC02-4161-8629-4E6D9B5A4CCB
wdtn:P356
n12:CIRCOUTCOMES.118.005287
wdt:P356
10.1161/CIRCOUTCOMES.118.005287